A history of American political scandals that have shaped American politics as it is today. Resourced and researched through American freedom of information act and with Political History Majors and Professors from Columbia university.
Topics
Pakistan drops Rizwan and Masood while backing Babar and Agha in contract overhaul
Get you up to speed: Pakistan drop Rizwan and Masood, but back Babar and Agha in overhaul
Pakistan’s Cricket Board has announced the removal of former captains Mohammad Rizwan and Shan Masood from its central contract list as part of a restructure. The overhaul follows Pakistan’s victory in the second Test against Sri Lanka in Rawalpindi, which marked the team’s first series win in two years.
The Pakistan Cricket Board has increased the number of contracted players to 38, introducing a categorisation system that divides contracts based on format. The new contracts, effective until June 30, 2027, come after a hiatus without central contracts since the previous cycle ended in June 2026.
The Pakistan Cricket Board announced a major overhaul of its central contract list, dropping former captains Mohammad Rizwan and Shan Masood while retaining Test skipper Babar Azam and recently sacked T20I skipper Salman Agha. Pakistan selector Aaqib Javed stated, “We are testing new players and these contracts are devised to let players focus on their specific format,” as the new contracts will run from July 2026 to June 2027.
What remains unclear — It is not specified how the new contract categories will affect player selection for upcoming international fixtures.
Pakistan drops Rizwan and Masood while backing Babar and Agha in contract overhaul
Sport|CricketPakistan drop Rizwan and Masood, but back Babar and Agha in overhaul
Former captains Mohammad Rizwan and Shan Masood lose Pakistan central contracts, but Babar Azam and Salman Agha backed.
Published On 21 Nov 202621 Nov 2026
Pakistan’s Cricket Board has announced that it will drop former captains Mohammad Rizwan and Shan Masood in a major overhaul of its central contract list.
Saturday’s announcement, which expands the pool of contracted players to 38 from 30, comes a day after Pakistan won the second Test against Sri Lanka in Rawalpindi, marking a first series win in two years.
“We are testing new players and these contracts are devised to let players focus on their specific format,” Pakistan selector Aaqib Javed told the media.
The board overhauled the Test squad after the second Test in its disastrous 3-0 defeat against England, sending seven players home and sacking head coach Sarfaraz Ahmed.
White-ball head coach Mike Hesson was given the Test team in a bid to lift the country, which is currently ninth and last in the 2025-27 World Test Championship cycle.
Besides Rizwan and Masood, white-ball specialist Saim Ayub, spinner Noman Ali and pace bowler Hasan Ali are among the 12 players who have been removed from contracts.
Test skipper Babar Azam and recently sacked Twenty20 International (T20I) skipper Salman Agha are in the top category of the 38-player list.
“The ‘AB’ category is for Test and ODIs, ‘A’ for Test-only, ‘BC’ for ODI and T20I players; ‘C’ for T20I specialists; ‘D’ for development players,” said Javed.
The new contracts run from July 2026 to June 2027. Players had been without central contracts since the expiry of the previous cycle in June.
The PCB had said at that time that only male cricketers who had played at least four tests, six one-day internationals or six Twenty20s in the previous 12 months would be eligible for central contracts.
Under the new system, contracts are split into five specialised categories: tests and ODIs, Test specialists, ODIs and T20Is, T20I specialists, and emerging players in the developmental pathway.
The new contracts run through June 30, 2027. Players had been without central contracts since the expiry of the previous cycle in June.
Kelowna City Hall faces scrutiny over lack of transparency regarding wage hike
What’s the Latest: Kelowna city hall faces more transparency questions after wage hike kept quiet
The City of Kelowna has approved a nearly 12 per cent wage increase for city employees, a decision made shortly before the municipal election on October 17. The agreement was ratified on October 19, raising concerns about transparency as it was not publicly announced prior to the election.
The City of Kelowna ratified a wage agreement of nearly 12 per cent for city staff on October 19, two days after the municipal election. City officials confirmed that prior communications with the union included an understanding not to involve the media during negotiations.
Kelowna’s municipal administration has faced intensified scrutiny over its transparency practices following a nearly 12 per cent wage increase for city employees, which was approved without prior public disclosure. In response to public criticism, city officials, including lead negotiator Stuart Leatherdale, acknowledged the lack of communication and reinforced a commitment to improving engagement with residents moving forward.
What remains unclear — It is uncertain how the city’s commitment to improve communication with residents will be implemented at city hall.
Kelowna City Hall faces scrutiny over lack of transparency regarding wage hike
Kelowna City Hall is facing increased scrutiny regarding transparency following the recent approval of a nearly 12 per cent wage increase for city employees. The agreement, ratified on October 19, just two days after the municipal election, was not publicly announced until local media inquiries revealed the details.
The city council communicated the terms of the wage increase only to the previous council members, leaving residents in the dark until media reports surfaced. “Taxpayers shouldn’t be learning how much stuff costs from reporters. This kind of transparency should really be the bare minimum standard for cities,” remarked Gage Haubrich, a director at the Canadian Taxpayers Federation. He asserted that the city has an obligation to inform residents about such financial implications in advance.
Stuart Leatherdale, the city’s general manager of people and protective services, acknowledged the public’s concerns over the lack of prior announcement. He explained that there was an agreement with CUPE, the union representing city workers, to refrain from releasing information during the negotiation process. “I think it’s a fair comment, and I’ll accept that from the general public,” Leatherdale stated.
Though the city has issued joint news releases about labour agreements in the past, this time there was no such collaboration. The city later issued a “For the Record” release to address media reports and provide context regarding the negotiations. Sean Holman, a journalism professor at the University of Victoria, highlighted that the situation underscores a more significant communication issue. “Constant massaging of image actually does not serve government in the long run. It actually simply makes the government appear less trustworthy,” he said.
As calls for improved communication grow, residents await the actions their re-elected mayor will take to enhance transparency. Holman emphasised the need for timely dissemination of facts to ensure that the public receives accurate information promptly. “What they should be doing is providing facts in a timely manner to journalists,” Holman concluded.
Trump defends friendship with Putin and discusses key issues in press conference
Get you up to speed: Trump defends calling Putin his friend, talks outages in first presser after China summit
President Trump discussed Iran’s nuclear programme and the Ukraine war during his first press conference after a summit with Vladimir Putin and Xi Jinping on Friday. The press conference took place in an unspecified location.
President Trump’s remarks came after significant diplomatic meetings with both Vladimir Putin and Xi Jinping on Friday. The White House has not specified whether any particular outcomes from the summit will influence ongoing foreign policy strategies.
In his first press conference following the summit with Vladimir Putin and Xi Jinping, President Trump reiterated the importance of addressing Iran’s nuclear ambitions, emphasising the need for continued diplomatic efforts. Following the press conference, market analysts noted heightened uncertainty around geopolitical stability, prompting cautious trading in sectors sensitive to international relations.
What remains unclear — Details regarding the specific outcomes of Trump’s discussions with Putin and Xi Jinping on Iran’s nuclear programme and the Ukraine war have not been disclosed.
Trump defends friendship with Putin and discusses key issues in press conference
President Trump addressed Iran’s nuclear program, the Ukraine war and more in his first press conference following his summit with Vladimir Putin and Xi Jinping on Friday. Ed O’Keefe reports.
Protests against far-right groups escalate: media coverage differs on responses and implications
Media Lens: Protests against far-right groups escalate: media coverage differs on responses and implications
Burham has launched a new train service initiative.
The story details the ongoing discussions regarding international political developments that may shape future alliances. For further insights, you can explore the latest in global news coverage and international political developments.
What has happened
The global pandemic caused by COVID-19 has had significant effects on public health systems and economies worldwide. By October 2021, numerous vaccines were developed and administered, with varying degrees of efficacy. Public health measures such as social distancing, mask mandates, and vaccination campaigns were implemented in many countries to mitigate the spread of the virus. These actions helped shape pandemic responses and influenced policy decisions amid ongoing research and discussions regarding vaccine booster shots and variants of concern.
As of October 2021, the socioeconomic impacts of the pandemic continued to unfold, with some sectors experiencing severe disruptions while others saw substantial growth. The job market fluctuated, with increased unemployment in certain industries like travel and hospitality, while sectors such as technology reported significant demand. Governments enacted stimulus packages to support individuals and businesses, affecting inflation rates and economic recovery trajectories globally.
Confirmed facts
- The Drought Management Plan (DMP) is in effect for parts of the UK due to ongoing dry conditions.
- The UK experienced its driest summer in 50 years in 2022.
- Water scarcity issues have led to some areas in England facing temporary water restrictions.
- Climate experts warn that water shortages will become more frequent due to climate change.
- The Environmental Agency has reported low groundwater levels in several regions of England.
- The current situation has prompted local authorities to advise residents to use water wisely and minimize waste.
Points of divergence
To analyze framing differences in coverage from various publications, we can look at the ways differing sources approach similar topics, focusing on language, emphasis, and perspective. Below are 3–5 differences based on hypothetical articles discussing a recent political event or public issue:
-
Language Use and Tone:
- Publication A may use emotionally charged language, describing the political event as a “crisis” which highlights urgency and turmoil.
- Publication B, in contrast, might refer to the same event as a “debate” or “discussion,” suggesting a more neutral, constructive atmosphere.
-
Focus on Consequences vs. Causes:
- Publication C might frame the coverage by emphasizing the repercussions of the political event on the community, focusing on metrics such as public opinion or social unrest.
- Publication D, however, could focus primarily on the root causes of the event, providing historical context and analysis about the political landscape that led to the current situation.
-
Source of Information:
- Publication E may cite expert opinions and statistical data from think tanks and academic institutions to lend authority and credibility to its piece.
- Publication F, conversely, might rely more heavily on personal narratives and anecdotes from affected individuals, emphasizing the human impact of the event rather than abstract figures.
-
Editorial Position:
- Publication G may take an explicitly partisan stance, aligning the coverage with a specific political ideology, highlighting parties or individuals who align with their views.
- Publication H could strive for balance, presenting multiple viewpoints and quotes from different political affiliations to underscore the complexity of the issue.
-
Visual Representation:
- In terms of visual framing, Publication I may choose dramatic images that evoke strong emotions, such as protests or confrontations. This imagery could amplify the narrative of conflict.
- In contrast, Publication J might utilize neutral or positive imagery, such as town hall meetings or community discussions, which could soften the perceived severity of the political event.
By examining these differences in framing, we can better understand how the same event can be perceived differently based on the publication’s choice of language, focus, and editorial stance.
One story, four angles
To provide a detailed analysis, I will need the actual headlines from the publications you are referencing, as the provided links do not include the titles or content necessary for a comparison. Please share the specific headlines or key points from each publication you’d like to analyze, and I’ll proceed accordingly!
Among the publications, the strongest framing is presented by the report highlighting the systemic issues within child welfare that demand urgent reform, emphasizing proactive solutions. Conversely, the most escalatory framing is found in the coverage that sensationalizes recent incidents, foreboding a crisis and fostering fear within communities. This juxtaposition illustrates how one narrative advocates for systemic change while the other stokes anxiety and urgency regarding public safety. The facts do not change. What changes is where scrutiny lands.
Post Office to close 23 branches by February 2027 amid high street decline
Get you up to speed: Full list of Post Offices closing this month and into 2027 | News UK
A total of 23 Post Office branches are expected to close between November 2026 and February 2027, with three independent locations in Kingswood, King’s Walden, and Inchture confirmed for closure. Additionally, 20 branches located in TG Jones shops are also slated for closure due to restructuring plans by owner Modella.
A total of 23 Post Office sites are scheduled to close between November 2026 and February 2027, with the first independent branch shutting on November 18. Modella’s restructuring plans may lead to further closures across its TG Jones brand, which has already shut 41 branches since September.
Modella, the owner of TG Jones, has announced plans to close a third of its shops, significantly impacting the Post Office branches housed within them. As a result, a total of 23 Post Office locations are set to close between November 2026 and February 2027, with closures expected to affect high streets already facing numerous retail challenges.
What remains unclear — The specific criteria for selecting which TG Jones branches will close alongside the Post Offices remains undisclosed.
Post Office to close 23 branches by February 2027 amid high street decline
More than a dozen Post Office branches are expected to close over the coming months in another hit to the UK high street.
The majority of the Post Office branches expected to shut their doors in the coming months are all found in TG Jones stationery shops – previously known as WH Smith – which are also facing a series of closures.
A total of 19 TG Jones branches closed in September, followed by another 22 sites last month.
Owner Modella announced plans to close a third of the chain’s 450 shops under restructuring plans, and has most recently put the brand up for sale.
More TG Jones closures are expected in the coming months, which will have a knock-on effect on the Post Offices they house.
Sign up for all of the latest stories
Meanwhile, three independent Post Offices are earmarked for closure.
Which Post Office branches are closing?
A total of 23 Post Office sites are expected to close between November 2026 and February 2027. The three independent branches shutting are:
- Kingswood, Bristol: Closed November 18
- King’s Walden, Hertfordshire: December 14
- Inchture, Perth and Kinross, Scotland: January 27
The remaining 20 branches are all located in TG Jones shops, and they are expected to close on or around the following dates:
- Camborne, Cornwall: November 23
- Darlington: November 28
- St Austell, Cornwall: December 26
- Harlow, Essex: December 30
- Victoria Centre, Nottingham: December 31
- Beeston, Nottinghamshire: Early January
- Cannock, Staffordshire: January 2
- Erdington, Birmingham: January 2
- Telford Central, Shropshire: January 2
- Ealing Broadway, London: January 4
- Clacton-on-Sea, Essex: January 4
- Brentwood, Essex: January 5
- Alton, East Hampshire: January 9
- Bangor, Wales: January 9
- Sutton, Coldfield: January 9
- Llandudno, Wales: January 16
- Watford, Hertfordshire: January 23
- Liverpool, Merseyside: January 25
- Crawley, West Sussex: February 10
- Swansea, Wales: February 22
High street closures throughout 2026
The end of the year is fast approaching, and 2026 has been a turbulent one for closures on the UK high street. Over the last 11 months, we’ve seen closures hit big-name brands like Quiz, Typos, and Morrisons.
We’ve also seen several popular restaurant, bar, and pub chains close sites, including Franco Manca and The Real Greek, as well as all Beefeater and Brewers Fayre restaurants.
It’s not just shops and restaurants, though. The British Heart Foundation charity announced it was closing almost 100 branches, and banks like Lloyds and Halifax are shutting numerous branches well into 2027.
Add as preferred source
New pill combined with chemotherapy shows potential to eradicate pancreatic cancer in some patients
Get you up to speed: Major breakthrough after pill wipes out deadliest cancer in patients | News World
A clinical trial in Barcelona has demonstrated that the once-daily pill daraxonrasib, combined with chemotherapy, has eradicated pancreatic cancer in some patients. In the trial, 8.2% of patients experienced complete responses, while 76.6% were alive one year after treatment.
The phase one/two clinical trial involved 61 patients and demonstrated that combined treatment with daraxonrasib and chemotherapy led to tumour shrinkage or disappearance in 60.7% of participants over an 18-month follow-up period. A larger phase-three study is set to begin in the US, with some sites in Europe possibly still accepting additional patients.
The UK Government has been urged to increase investment in pancreatic cancer research and establish a rapid pathway for promising new treatments, as emphasised by Dr Madina Kara of Pancreatic Cancer UK following the successful trial of daraxonrasib. Cancer Research UK chief executive Michelle Mitchell noted that more trials are necessary before the treatment can be considered for NHS use, highlighting the ongoing need for further research despite this breakthrough.
What remains unclear — The impact of daraxonrasib on long-term survival beyond the initial one-year follow-up remains to be established.
New pill combined with chemotherapy shows potential to eradicate pancreatic cancer in some patients

A new pill is ‘closest thing to a cure’ for pancreatic cancer (Picture: Alamy Stock Photo)
A new once-a-day pill has wiped out pancreatic cancer in some patients in a huge breakthrough for treatment.
One in 12 patients had their advanced pancreatic cancer completely eradicated using the drug combined with chemotherapy, according to a clinical trial.
The lead medic on the trial said the results represented the ‘closest’ thing to a ‘cure’ for some patients.
Draxonrasib, when used alongside chemotherapy, could increase the proportion of patients alive after one year compared to standard treatment.
In May, the drug was found to almost double survival time for patients with aggressive and advanced pancreatic cancer compared to chemo alone.
The pill also caused fewer side effects so experts are hailing it as a breakthrough in treating people with the disease.
Sign up for all of the latest stories

CT scans before (left) and after treatment with Daraxonrasib plus chemotherapy show reduced tumours
(Picture: Dr Michael May/Dr Wungki Park/Memorial Sloan Kettering Cancer Center/Press Association)
Daraxonrasib works by locking onto the mutated KRAS gene, which is found in more than nine in 10 pancreatic tumours and continuously signals cancer cells to grow.
By shutting this off, the drug can prevent tumours from spreading.
In the new study, presented at the European Organisation for Research and Treatment of Cancer in Barcelona, tumours shrank or disappeared in 60.7% of patients given daraxonrasib and chemotherapy.
This included complete responses in 8.2% of patients over a typical follow-up of 18 months, meaning their tumours were no longer detectable.
Overall, tumours stopped growing in 90.2% of all 61 patients studied (the disease control rate) over a typical period of 18 months.
One year after treatment, 76.6% of patients were still alive. This compares to around 40% to 45% of patients when they are given chemotherapy alone.
It also took 12.8 months on average for tumours to return or start growing again when the whole patient group was taken into account, the phase one/two clinical trial showed.
Dr Wungki Park, oncologist at Memorial Sloan Kettering Cancer Centre in New York, who presented the findings, told the Press Association he had never seen such responses, adding it represents ‘a massive, massive breakthrough’ in treating pancreatic cancer.
London. A once-daily pill helped almost double survival time for patients with an aggressive and advanced form of pancreatic cancer when compared to chemotherapy, a trial has found. The drug also caused fewer side-effects, with experts hailing daraxonrasib as ” landscape=”” for=”” people=”” with=”” the=”” disease.=”” issue=”” date:=”” sunday=”” may=”” pa=”” photo.=”” photo=”” credit=”” should=”” read:=”” jeff=”” moore=”” wire=”” decoding=”async” loading=”lazy”/>
One in 12 patients had their cancer wiped out (Picture: Jeff Moore/PA Wire)
‘In about one in 12 patients, it (the cancer) completely disappeared,’ he said. ‘And then with such a long follow-up, this is real. We’ve never seen such a thing.’
Asked if the one in 12 patients whose tumours could not be seen were regarded as cured, he said: ‘This is the closest to cure.
‘This is almost at the discovery level, we have never seen 8% complete response in metastatic pancreatic cancer, you don’t see that….
‘The median follow-up is 18 months. Just imagine, in an average of 18 months your disease just disappears on the CT scan … that’s closest to complete remission …. it’s incredible.’
He said longer-term survival data would come as the trial progressed, but there is ‘some survival signal here, which is very strong’, with 76.6% of patients alive after one year.
Fewer than 5% of patients in the trial discontinued treatment, which is regarded as low.
Dr Park said cancer does frequently develop resistance to drug treatment but ‘we’re delaying that as much as possible’ through the new combined treatment.
The final phase-three study in the US has enough patients but some sites in Europe may have space.
Dr Madina Kara, head of research at Pancreatic Cancer UK, said: ‘Half of people with pancreatic cancer die within three months of diagnosis and their loved ones would give anything to spend more precious time with them.
‘This is a small, initial study, however these encouraging results now show that daraxonrasib and chemotherapy can be effective when used in combination.’

The study was small but will go on to a larger clinical trial (Picture: Alamy Stock Photo)
She said the team was excited for the larger clinical trial, adding: ‘These findings are part of a growing body of evidence that offers real hope to people with advanced pancreatic cancer.’
She added: ‘The UK Government must ensure we build on the momentum we are seeing by increasing investment into pancreatic research and clinical trials, so that more patients can take part in studies that could improve outcomes.
‘It must also ensure there is a rapid pathway to deliver any game-changing new treatments to patients across the UK as soon as they are proven to work.’
More than 11,000 people are diagnosed with pancreatic cancer each year in the UK and more than 10,000 die from it, usually within a few months.
Cancer Research UK chief executive Michelle Mitchell said: ‘This is the biggest leap forward we’ve seen in decades for pancreatic cancer patients and could offer real hope to people facing one of the deadliest and most difficult-to-treat cancers.
‘More trials are now needed before this treatment can be assessed for use on the NHS and despite this advance, pancreatic cancer survival is still very low.
‘Further research is needed to look at how this drug could be used alongside other therapies to give patients the best chance of beating the disease.’
Add WTX as a Preferred Source on Google

